Literature DB >> 11499848

The multiple propensity score for analysis of dose-response relationships in drug safety studies.

J Wang1, P T Donnan, D Steinke, T M MacDonald.   

Abstract

In order to detect adverse drug reactions, large observational drug safety studies are necessary as randomized clinical trials rarely have enough power. However, in order to obtain reliable results the issue of confounding, especially confounding by indication, should be addressed. We proposed a multiple propensity score, which is an extension of the propensity score, to reduce the bias in a dose-response analysis in a drug safety study. The multiple propensity score has similar properties to the propensity score in Rosenbaum and Rubin.(1) Using the propensity score for bias reduction of the risk ratio was considered. We used the multiple propensity score in a study of the dose-response relationship between diclofenac prescriptions and hospitalization for gastrointestinal bleeding and perforation using a record linkage database. We found that the unadjusted risk ratios were biased downwards due to confounders and that this bias was reduced by using stratification based on the multiple propensity score.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11499848     DOI: 10.1002/pds.572

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  A pharmacoepidemiological network model for drug safety surveillance: statins and rhabdomyolysis.

Authors:  Ben Y Reis; Karen L Olson; Lu Tian; Rhonda L Bohn; John S Brownstein; Peter J Park; Mark J Cziraky; Marcus D Wilson; Kenneth D Mandl
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

2.  Measuring dosage: a key factor when assessing the relationship between prenatal case management and birth outcomes.

Authors:  Jaime C Slaughter; L Michele Issel; Arden S Handler; Deborah Rosenberg; Debra J Kane; Leslie T Stayner
Journal:  Matern Child Health J       Date:  2013-10

3.  Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment.

Authors:  A Finckh; H K Choi; F Wolfe
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

4.  Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

Authors:  Gregory A Grabowski; Katherine Kacena; J Alexander Cole; Carla E M Hollak; Lin Zhang; John Yee; Pramod K Mistry; Ari Zimran; Joel Charrow; Stephan vom Dahl
Journal:  Genet Med       Date:  2009-02       Impact factor: 8.822

5.  Optimal caliper width for propensity score matching of three treatment groups: a Monte Carlo study.

Authors:  Yongji Wang; Hongwei Cai; Chanjuan Li; Zhiwei Jiang; Ling Wang; Jiugang Song; Jielai Xia
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.